36 results about "Medical abortion" patented technology

The invention provides a Chinese medicine compound preparation for preventing and treating the abnormal uterine bleeding after medical abortion, and relates to the gynecologic Chinese medicine field.By taking the anti-early pregnancy drugs, pregnant women can avoid the uteroventral operation, thus the suffering of patients can be relieved; however, the problems of excessive haemorrhage and long bleeding time can occur; the curative effect of the existing medicines is dissatisfactory, and no medicine, which is specially used for treating the abnormal uterine bleeding after medical abortion andhas good curative effect, comprehensive efficacy but no side effect, is reported. The invention takes motherwort as monarch drug, purslane, raw cattail pollen and radix cyathulae as ministerial drugs, bitter orange, agrimony, angelica and radix codonopsitis as adjuvant drugs and liquoric root as envoy drug to prepare the compound preparation. Proved by plenty of clinical experiments, the invention has the advantages of activating blood circulation but no massive haemorrhage, removing stasis, clearing heat, stopping bleeding but no stagnation, nourishing blood, invigorating qi, shortening bleeding time, reducing bleeding amount, no toxic and side effect and convenience for being taken.

The invention discloses a sea cucumber flower extractive used for promoting postpartum uterus contraction; the sea cucumber flower extractive is the water-soluble matter extracted from the sea cucumber flower, which is the sea cucumber processing waste. The sea cucumber flower extractive has the function of contracting uterus and is used for treating postpartum hemorrhage and incomplete restoration of uterus after medical abortion operation and induced abortion operation.

The invention relates to a medicine for treating vaginal bleeding after medical abortion. The medicine is prepared from the following medicinal raw materials in parts by weight: 80 parts of scorzonera albicaulis bunge, 70 parts of pink reineckea herb, 60 parts of helicteres isora, 55 parts of schisandra lancifolia, 50 parts of pampanin shuteria herb, 55 parts of sida acuta, 45 parts of primula efarinosa pax, 35 parts of cissus hexangularis and 30 parts of licorice root. The medicine is reasonable in formula and exact in curative effect, and can be used for effectively treating vaginal bleeding after medical abortion.

The invention relates to a medicament for treating infertility of obstructive uterine tube. The infertility of obstructive uterine tube leads to the clinical symptoms of medical histories such as infertility, pelvic pain, artificial abortion or not and medical abortion. Through an gynecological examination, the adnexa areas at both sides show thickening and have tenderness, and the uterine tube is tested to be completely obstructed or partially obstructed. After a long-term research and clinical verifications, an oral medicament of traditional Chinese medicine for treating infertility of obstructive uterine tube with better curative effect is finally found by the inventor. The dosage of the medicament compositions provided by the invention is also gained through a great deal of development by the inventor and the optimum proportion is as follow: 30 parts of salvia miltiorrhiza, 12 parts of peach seed, 12 parts of cortex moutan, 9 parts of Chinese angelica, 15 parts of szechuan lovage rhizome, 15 parts of radix paeoniae rubra, 9 parts of red flower, 15 parts of bitter orange, 15 parts of dandelion, 15 parts of barbed skullcap herb, 12 parts of stir-baked squama manitis, 15 parts of spina gleditsiae, 3 parts of centipede, 3 parts of pseudo-ginseng and 15 parts of coke hawthorn. Each medicament functions to generate the synergistic effect by combining all which has the effects of activating blood, dissolving stasis and dredging collaterals, and thus effectively treating the infertility of obstructive uterine tube.

The invention discloses a traditional Chinese medicinal composition for treating haemorrhage after medical abortion and a preparation method thereof; the traditional Chinese medicinal composition is prepared from the following raw materials according to parts by weight: 6-7.3 parts of motherwort, 1.3-2.2 parts of raw cattail pollen, 1-2.5 parts of trogopterus dung, 1-2.5 parts of radix astragalus, 0.5-1.5 parts of baked ginger, and 0.5-1.5 parts of peach kernel. The traditional Chinese medicinal composition has the effects of eliminating stasis and stopping bleeding, and is applied to treating haemorrhage of uterus blockage, deciduas residue after medical abortion and haemophilia. The invention further discloses a preparation method of the traditional Chinese medicinal composition.

The invention relates to medicine used for medical abortion. The medicine comprises, by weight, 50 parts of ginseng fruits, 40 parts of pansy, 35 parts of teucrium viscidum, 30 parts of dracontomelon duperreanum, 30 parts of bearded mallotus roots, 30 parts of lysimachia microcarpa, 20 parts of lawn pennywort herbs, 20 parts of Japanese raspberry roots, 10 parts of lysimachia longipes and 10 parts of elatostema oblohgifolium fu. The raw materials are easy to obtain, the treatment effect is definite, and testing verifies that the effective rate is high, and the cost is low.

The invention discloses a razor clam extractive used for promoting postpartum uterus contraction; the razor clam extractive is the water-soluble matter extracted from the razor clam meat, has the function of contracting uterus and is used for treating postpartum hemorrhage and incomplete restoration of uterus after medical abortion operation and induced abortion operation.

The invention provides a placenta-targeted nanoparticle, which can be used for medical abortion, which comprises a hydrophobic inner core, a monolayer lipid molecular layer wrapping the hydrophobic inner core and a hydrophilic outer shell. The hydrophobic inner core includes a hydrophobic polymer and Its loaded target delivery includes abortion drugs; the composition of the hydrophilic shell is an amphiphilic macromolecular compound grafted with a polypeptide targeting placenta-like chondroitin sulfate A, and the hydrophobic end of the amphiphilic macromolecular compound Interspersed in the monolayer lipid molecular layer, the hydrophilic end of the amphiphilic macromolecular compound is connected to the polypeptide through an amide bond, and the polypeptide is exposed outside the monolayer lipid molecular layer, wherein the amino acid sequence of the polypeptide is selected from SEQ ID NO: One or more of the amino acid sequences shown in 1-SEQ ID NO:3. The invention also provides a preparation method of the placenta-targeted nanoparticle and its application in the preparation of mammalian abortion medicine.

The invention belongs to the technical field of medicine, and particularly relates to nursing medicine used for treating colporrhagia after a medical abortion and a preparation method thereof. The nursing medicine is composed of hairyvein agrimony, astragalus membranaceus, cortex moutan, codonopsis pilosula, dahurian patrinia herbs, rehmannia glutinosa, peach seeds, red paeony roots and other components. The nursing medicine has the significant treatment effects of cooling blood for hemostasis, replenishing qi to strengthen superficial body resistance, replenishing essence and marrow, removing stasis to ease pain and clearing away heat and toxic materials and has an extremely strong targeted nursing effect on colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion; as is proven by clinical application, the nursing medicine is definite in treatment effect, takes effect fast, has no toxic and side effect or untoward effect and can serve as effective nursing medicine for treating colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion.